Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

ZYDUS LIFESCIENCES LTD.

NSE : ZYDUSLIFEBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE1189.0041.05 (+3.58 %)
PREV CLOSE () 1147.95
OPEN PRICE () 1160.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 311978
TODAY'S LOW / HIGH ()1142.50 1194.20
52 WK LOW / HIGH ()835.85 1205.65
NSE1189.2039.2 (+3.41 %)
PREV CLOSE() 1150.00
OPEN PRICE () 1160.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1189.20 (2421)
VOLUME 3168135
TODAY'S LOW / HIGH() 1142.10 1195.40
52 WK LOW / HIGH ()835.5 1205
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1995

Management Info :

Pankaj R Patel - Chairman Sharvil P Patel - Managing Director

Registered Office :

Address : Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway,
Ahmedabad,
Gujarat-382481

Phone : 079-71800000 / 48040000

Registrar's Details : MUFG Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE
NEWS
26Aug Zydus Lifesciences incorporates wholly
Zydus Lifesciences has incorporated wholly owned subsidiary (WOS) in the..
26Aug Zydus Lifesciences jumps on incorporat
Zydus Lifesciences is currently trading at Rs. 1139.95, up by 9.95 point..
21Aug Zydus Lifesciences gets USFDA’s final
Zydus Lifesciences has received final approval from the United States Fo..
12Aug Zydus Lifesciences’ arm enters into op
Zydus Lifesciences’ wholly-owned subsidiary -- Sentynl Therapeutics, Inc..
12Aug Zydus Lifesciences rises as its arm en
Zydus Lifesciences is currently trading at Rs. 1194.00, up by 14.00 poin..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit339635598
Gross Profit 4557 43819
Operating Profit 710755929
Net Sales 28722114840
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Torrent Pharma (BSE)
 5025.00 (2.80%)
M.Cap ( in Cr)
191134.85
Wockhardt (BSE)
 1960.90 (4.29%)
M.Cap ( in Cr)
31863.09
Acutaas Chemicals (BSE)
 3332.55 (2.16%)
M.Cap ( in Cr)
27283.96
Glaxosmithkline Phar (BSE)
 3068.35 (1.35%)
M.Cap ( in Cr)
51979.70
Shilpa Medicare (BSE)
 900.10 (4.65%)
M.Cap ( in Cr)
17604.32
Shareholding Pattern
PROMOTERS 75.01%
NON-INSTITUTION 6.83%
FI/BANKS/INSURANCE 5.96%
MUTUAL FUNDS/UTI 5.12%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX76933.59-539.35 (-0.70%)
NIFTY24090.85-116.90 (-0.48%)
Dow Jones 53569.44105.56 (0.20%)
Nasdaq 26541.35411.15 (1.57%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI